H31.12 Diffuse secondary atrophy of choroid

Name of the Condition

• Diffuse secondary atrophy of choroid (ICD Code: H31.12)

Summary

Diffuse secondary atrophy of the choroid is a condition characterized by the widespread degeneration and thinning of the choroid, the vascular layer of the eye, resulting from an underlying cause. This process can lead to structural changes in choroidal tissue, potentially impacting retinal health and visual function depending on the extent and location of the atrophy.

Causes

Diffuse secondary atrophy of the choroid typically results from systemic diseases, chronic inflammation, or vascular insufficiency affecting ocular blood flow. Common underlying causes include hypertension, atherosclerosis, autoimmune disorders, or long-term exposure to certain environmental factors. In some cases, it may be associated with infections or neoplastic processes.

Risk Factors

• Advanced age
• Systemic vascular diseases (e.g., hypertension, atherosclerosis)
• Chronic ocular inflammation or infection
• Autoimmune disorders
• Prolonged exposure to ultraviolet light
• Genetic predispositions

Symptoms

• Gradual loss of peripheral or central vision
• Blurred or distorted vision
• Difficulty adapting to low light conditions
• Visual field defects
• Reduced visual acuity in advanced cases

Diagnosis

Diagnosis involves a comprehensive eye examination, including dilated fundus evaluation to assess choroidal structure. Imaging techniques such as optical coherence tomography (OCT) or fluorescein angiography may be used to evaluate choroidal thickness and vascular integrity. Laboratory tests or systemic evaluations may be performed to identify underlying causes.

Treatment Options

Treatment focuses on managing underlying systemic conditions and preserving remaining vision. This may include controlling vascular risk factors, anti-inflammatory therapies, or laser photocoagulation in specific cases. Low-vision aids and rehabilitation may be recommended for symptomatic relief.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and severity of choroidal atrophy. Regular follow-up with an ophthalmologist is essential to monitor disease progression and adjust management as needed. Early intervention may help slow further degeneration in some cases.

Complications

• Progressive vision loss
• Retinal degeneration
• Increased risk of choroidal neovascularization
• Difficulty with daily activities due to visual impairment

Lifestyle & Prevention

• Manage systemic vascular conditions (e.g., blood pressure, cholesterol)
• Protect eyes from excessive ultraviolet light with sunglasses
• Maintain a balanced diet rich in antioxidants
• Avoid smoking, which may exacerbate vascular damage
• Regular eye examinations for early detection

When to Seek Professional Help

Seek prompt evaluation if you experience sudden changes in vision, persistent blurriness, or difficulty seeing in low light. Early intervention may help address underlying causes and preserve vision.

Tips for Medical Coders

Document the underlying cause or associated systemic condition when coding H31.12, as this code specifies secondary atrophy. Ensure clinical documentation supports the diffuse nature of the choroidal atrophy and any contributing factors to justify code assignment.